Inorganic arsenic: A need and an opportunity to improve risk assessment

Environmental Health Perspectives

Volumn 105, Issue 10, 1997, Pages 1060-1067

  Chappell, W R ^a   Beck, B D ^b   Brown, K G ^c   Chaney, R ^d   Richard Cothern, C ^e   Irgolic, K J ^f   North, D W ^g,h   Thornton, I ⁱ   Tsongas, T A ^j  

^a UNIVERSITY OF COLORADO   (United States)

^b GRADIENT   (United States)

^c Kenneth G Brown Inc   (United States)

^d U S DEPARTMENT OF AGRICULTURE   (United States)

^e U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^f UNIVERSITY OF GRAZ   (Austria)

^g Decision Focus Inc   (United States)

^h STANFORD UNIVERSITY   (United States)

ⁱ IMPERIAL COLLEGE LONDON   (United Kingdom)

^j WASHINGTON STATE UNIVERSITY   (United States)

more..

Author keywords

Arsenic; Cancer; Dose response; Drinking water; Food; Risk assessment

Indexed keywords

ARSENIC; DRINKING WATER;

BLADDER CANCER; CONCENTRATION RESPONSE; ENVIRONMENTAL EXPOSURE; FOOD CONTAMINATION; HEALTH; MAXIMUM ALLOWABLE CONCENTRATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SKIN CANCER; SYMPOSIUM; UNITED STATES; WATER STANDARD; WORKSHOP;

EID: 0031419682     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.971051060     Document Type: Review

References (88)

1. U.S. EPA. Risk Assessment Forum, Special Report on Ingested Inorganic Arsenic: Skin Cancer, Nutritional Essentiality. EPA 625/3-87-013. Washington, DC:U.S. Environmental Protection Agency, 1988.
2. Hutchinson J. On some examples of arsenic-keratosis of the skin and arsenic-cancer. Trans Pathol Soc Lond 39:352-363 (1888).
3. Chappell WR, Abernathy CO, Cothern CR, eds. Arsenic Exposure and Health. Special Issue of Environmental Geochemistry and Health. Science and Technology Letters, Vol 16. Middlesex, England:Northwood, 1994.
4. Abernathy CO, Calderon RL, Chappell WR, eds, Arsenic Exposure and Health Effects. New York:Chapman & Hall, 1997.
5. Tseng W-P, Chu HM, How SW, Fong JM, Lin CS, Yen S. Prevalence of skin cancer in an endemic area of chronic arsenism in Taiwan. J Natl Cancer Inst 40:453-463 (1968).
6. Tseng W-P. Effects and dose-response relationship of skin cancer and blackfoot disease with arsenic. Environ Health Perspect 19:109-119 (1977).
7. Chen CJ, Chuang YC, You SL, Lin TM, Wu HY. A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br J Cancer 53:399-405 (1986).
8. Chen CJ, Chuang YC, Lin TM, Wu HY. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res 45:5895-5899 (1985).
9. Chen CJ, Chen CW, Wu MM, Kuo TL. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer 66:888-892 (1992).
10. Hopenhayn-Rich C, Biggs ML, Fuchs A, Bergoglio R, Tello EE, Nicolli H, Smith AH. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology 7:117-124 (1996).
11. Sancha AM, Rodriguez D, Vega F, Fuentes S, Salazar AM, Venturino AM, Moreno V, Baron AM. Human exposure to arsenic in water: a study of Atacamenan settlements in northern Chile. In: Book of Abstracts from SEGH International Conference on Arsenic Exposure and Health Effects, 28-30 July 1993, New Orleans, LA. Denver, CO:University of Colorado, 1993;68.
12. Chen C-J, Lin LJ, Hsueh YM. Ischemic heart disease induced by inorganic arsenic. In: Arsenic Exposure and Health. Special Issue of Environmental Geochemistry and Health. Science and Technology Letters, Vol 16 (Chappell WR, Abernathy CO, Cothern CR, eds). Middlesex, England:Northwood, 1994; 83-90.
13. Guha Mazumder DN, Das Gupta J, Santra A, Pal A, Ghose A, Sarkar S, Chattopadhaya N, Chakraborti D. Non-cancer effects of chronic arsenicosis with special reference to liver damage. In: Arsenic Exposure and Health Effects (Abernathy CO, Calderon RL, Chappell WR, eds). New York:Chapman & Hall, 1997; 112-123.
14. Chen CJ, Wu MM, Lee SS, Wang JD, Cheng SH, Wu HY. Artherogenicity and carcinogenicity of high-arsenic artesian well water. Arteriosclerosis 8:452-460 (1988).
15. Hsueh YM, Cheng GS, Wu MM, Yu HS, Kuo TL, Chen CJ. Multiple risk factors associated with arsenic-Induced skin cancer: effects of chronic liver disease and malnutritional status. Br J Cancer 71:109-114 (1995).
16. Smith AH, Hopenhayn-Rich C, Bates MN, Goeden HM, Hertz-Picciotto I, Duggan HM, Wood R, Kosnett MJ, Smith MT. Review of cancer risks from arsenic in drinking water. Environ Health Perspect 97:259-267 (1992).
17. Bates MN, Smith AH. Arsenic ingestion and internal cancers: a review. Am J Epidemiol 3:462-476 (1992).
18. Chatterjee A, Das D, Mandal BK, Samanta G, Banerjee P. The biggest arsenic calamity in the world. Analyst 120:643-650 (1995).
19. Chowdhury TR, Mandal BK, Samanta G, Basv GK, Chowdhury PP, Chanda CR, Karan NK, Lodh D, Dhar RK, Das D. Arsenic in ground-water in six districts of West Bengal, India - The biggest arsenic calamity in the world: the status report up to August, 1995. In: Arsenic Exposure and Health Effects (Abernathy CO, Calderon RL, Chappell WR, eds). New York:Chapman & Hall, 1997;93-111.
20. Saha KC. Chronic arsenical dermatosis from tube-well water in West Bengal during 1983-87. Indian J Dermatol 40:1-12 (1995).
21. Pearce F. Death and the devils water. New Scientist 147:14-15 (1995).
22. Del Razo LM, Hernandez JL, Garcia-Vargas GG. Urinary excretion of arsenic species in a human population chronically exposed to arsenic via drinking water. A pilot study. In: Arsenic Exposure and Health. Special Issue of Environmental Geochemistry and Health. Science and Technology Letters, Vol 16 (Chappell WR, Abernathy CO, Cothern CR, eds). Middlesex, England:Northwood, 1994;91-100.
23. Cebrian ME, Abores A, Aguilar M, Blakely E. Chronic arsenic poisoning in the north of Mexico. Hum Toxicol 2:121-133 (1983).
24. Niu S, Cao S, Shen E. The status of arsenic poisoning in China. In: Arsenic Exposure and Health Effects (Abernathy CO, Calderon RL, Chappell WR, eds). New York:Chapman & Hall, 1997;73-83.
25. Foy H, Tarmapai S, Eamchan P, Metdilogkul O. Chronic arsenic poisoning from well water in a mining area in Thailand. Asia-Pac J Public Health 6:150-152 (1992/1993).
26. Choprapawon C, Rodcline A. Chronic arsenic poisoning in Ronpibool Nakhon Si Thammarat, the southern province of Thailand. In: Arsenic Exposure and Health Effects (Abernathy CO, Calderon RL, Chappell WR, eds). New York:Chapman & Hall, 1997;69-77.
27. Luo ZD, Zhang YM, Ma L, Zhang GY, He X, Wilson R, Byra DM, Griffiths JG, Lai S, He L. Chronic arsenism and cancer in Inner Mongolia - consequences of well-water arsenic levels greater than 50 μg/l. In: Arsenic Exposure and Health Effects (Abernathy CO, Calderon RL, Chappell WR, eds). New York:Chapman & Hall, 1997;55-68.
28. Reid J. Arsenic occurrence: USEPA seeks clearer picture. Special Issue: Arsenic: the Quest for Answers. Am Water Works Assoc J 86:44-51 (1994).
29. Pontius FW, Brown KG, Chen CJ. Health implications of arsenic in drinking water. Special Issue: Arsenic: the Quest for Answers. Am Water Works Assoc J 86:52-63 (1994).
30. Borum DR, Abernathy CO. Human exposure to inorganic arsenic. In: Arsenic Exposure and Health. Special Issue of Environmental Geochemistry and Health. Science and Technology Letters, Vol 16 (Chappell WR, Abernathy CO, Cothern CR, eds). Middlesex, England: Northwood, 1994;21-30.
31. Davis MK, Reich KD, Tikkanen MW. Nationwide and California occurrence studies. In: Arsenic Exposure and Health. Special Issue of Environmental Geochemistry and Health. Science and Technology Letters, Vol 16 (Chappell WR, Abernathy CO, Cothern CR, eds). Middlesex, England:Northwood, 1994; 31-40.
32. World Health Organization. Guidelines for drinking-water quality: Recommendations, Vol I. Geneva:World Health Organization, 1993.
33. Hughes K, Meek ME. Arsenic in the Canadian general environment - evaluation of risks to health. In: Arsenic Exposure and Health. Special Issue of Environmental Geochemistry and Health. Science and Technology Letters, Vol 16 (Chappell WR, Abernathy CO, Cothern CR, eds). Middlesex, England: Northwood, 1994; 257-268.
34. Adams MA, Bolger PM, Gunderson EL. Dietary intake and hazards of arsenic. In: Arsenic Exposure and Health. Special Issue of Environmental Geochemistry and Health. Science and Technology Letters, Vol 16 (Chappell WR, Abernathy CO, Cothern CR, eds). Middlesex, England:Northwood, 1994; 41-50.
35. Lamarre L. The risks of utility hazardous air pollutants. Electric Power Research Institute J 20:6-15 (1995).
36. Electric Power Research Institute. Electric Utility Trace Substances Synthesis Report. EPRI-TR-104614. Palo Alto, CA:Electric Power Research Institute, 1994.
37. Office of Health and Environmental Assessment. Health Assessment Document for Inorganic Arsenic. EPA-600/8-83-021F. Washington, DC:U.S. Environmental Protection Agency, 1984.
38. Valberg PA, Beck BD, Boardman PD, Cohen JT. Likelihood ratio analysis of skin cancer prevalence associated with arsenic in drinking water in the U.S. Environ Geochem Health (in press).
39. Uthus EO. Evidence for arsenic essentiality. Eviron Geochem Health 14:55-58 (1992).
40. Uthus EO. Arsenic essentiality studies and factors affecting its importance. In: Arsenic Exposure and Health. Special Issue of Environmental Geochemistry and Health. Science and Technology Letters, Vol 16 (Chappell WR, Abernathy CO, Cothern CR, eds). Middlesex, England:Northwood, 1994;199-208.
41. U.S. EPA. Soil Screening Guidance Technical Background Document. Office of Solid Waste and Emergency Response. EPA/540/R-95/128, PB96-963502. Washington, DC:U.S. Environmental Protection Agency, 1996.
42. Brown KG, Boyle KE, Chen CW, Gibb HJ. A dose-response analysis of skin cancer from inorganic arsenic in drinking water. Risk Anal 9:519-528 (1989).
43. Safe Drinking Water Act Amendments of 1996. U.S. Public Law 104-182, 1996.
44. Society for Environmental Geochemistry and Health. Lead in Soil: Task Force Recommended Guidelines (Wixson BG, Davies BE, eds). Northwood, England:Science Reviews, 1993.
45. Wixson BG, Davies BE. Guidelines for lead in soil: proposal of the Society for Environmental Geochemistry and Health. Environ Sci Technol 28:26A-31A (1994).
46. Fowle JR, ed. Environ Geochem & Health 14, 1992.
47. National Research Council. Science and Judgment in Risk Assessment. Washington, DC:National Academy Press, 1994.
48. Brown KG, Abernathy CO. The Taiwan skin cancer risk analysis of inorganic arsenic ingestion: effects of water consumption rates and food arsenic levels. In: Arsenic Exposure and Health Effects (Abernathy CO, Calderon RL, Chappell WR, eds). New York:Chapman & Hall, 1997;260-271.
49. Schoof RA, Yost LJ, Valberg PA, Beck BD. Recalculation of the oral arsenic reference dose and cancer slope factor using revised assumptions of inorganic arsenic intake from food. Toxicologist 14:51 (1994).
50. Kempic JB. Arsenic removal technologies: an evaluation of cost and performance. In: Arsenic Exposure and Health Effects (Abernathy CO, Calderon RL, Chappell WR, eds). New York:Chapman & Hall, 1997;393-405.
51. Vahter M. Species differences in the metabolism of arsenic. In: Arsenic Exposure and Health. Special Issue of Environmental Geochemistry and Health. Science and Technology Letters, Vol 16 (Chappell WR, Abernathy CO, Cothern CR, eds). Middlesex, England:Northwood, 1994;171-180.
52. Buchet JP, Lauwerys R. Inorganic arsenic metabolism in humans. In: Arsenic Exposure and Health. Special Issue of Environmental Geochemistry and Health. Science and Technology Letters, Vol 16 (Chappell WR, Abernathy CO, Cothern CR, eds). Middlesex, England:Northwood, 1994;181-190.
53. Rudel R, Slayton TM, Beck BD. Implications of arsenic genotoxity for dose-response of carcinogenic effects. Regul Toxicol Pharmacol 23:87-105 (1996).
54. Brown KG, Chen CJ. Significance of exposure assessment to analysis of cancer risk from inorganic arsenic in drinking water in Taiwan. Risk Anal 15:475-484 (1995).
55. Guo HR. Arsenic in drinking water and skin cancer: comparison among studies based on cancer registry, death certificates, and physical examinations. In: Arsenic Exposure and Health Effects (Abernathy CO, Calderon RL, Chappell WR, eds). New York:Chapman & Hall, 1997;243-259.
56. Hopenhayn-Rich C, Smith AH, Goeden HM. Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. Environ Res 60:161-177 (1993).
57. Mushak P, Crocetti AF. Risk and revisionism in arsenic cancer risk assessment. Environ Health Perspect 103:684-689 (1995).
58. Slayton TM, Beck BD, Reynolds KA, Chapnick SD, Valberg PA, Yost LJ, Schoof RA, Gauthier TD, Jones L. Issues in arsenic cancer risk assessment [letter]. Environ Health Perspect 104:1012-1014 (1996).
59. Mushak P, Crocetti AF. Response: accuracy, arsenic, and cancer. Environ Health Perspect 104:1014-1018 (1996).
60. Carlson-Lynch H, Beck BD, Boardman PD. Arsenic risk assessment. Environ Health Perspect 102:354-356 (1994).
61. Smith AH, Biggs ML, Hopenhayn-Rich C, Kalman D. Arsenic risk assessment [letter]. Environ Health Perspect 103:13-15 (1995).
62. Beck BD, Boardman PD, Hook GC, Rudel RA, Slayton TM, Carlson-Lynch H. Response to Smith et al. Environ Health Perspect 103:15-17 (1995).
63. Hopenhayn-Rich C, Biggs ML, Smith AH, Kalman DA, Moore LE. Methylation study of a population environmentally exposed to arsenic in drinking water. Environ Health Perspect 104:620-628 (1996).
64. del Razo LM, Hernandez JL, Garcia-Vargas GG, Ostrosky-Wegman P, de Nava C, Cebrian ME. Urinary excretion of arsenic species in a human population chronically exposed to arsenic via drinking water. In: Arsenic Exposure and Health. Special Issue of Environmental Geochemistry and Health. Science and Technology Letters, Vol 16 (Chappell WR, Abernathy CO, Cothern CR, eds). Middlesex, England:Northwood, 1994;91-100.
65. del Razo LM, Garcia-Vargas GG, Vargas H, Albores A, Gonsebatt ME, Montero R, Ostrosky-Wegman P, Kelsh M, Cebrian ME. Altered profile of urinary arsenic metabolites in adults with chronic arsenicism: a pilot study. Arch Toxicol 71:211-217 (1997).
66. North DW, Selker F, Guardino T. The value of research on health effects of ingested inorganic arsenic. In: Arsenic Exposure and Health. Special Issue of Environmental Geochemistry and Health. Science and Technology Letters, Vol 16 (Chappell WR, Abernathy CO, Cothern CR, eds). Middlesex, England:Northwood, 1994;1-20.
67. Fowle III JR. Health effects of arsenic in drinking water: research needs. Environ Geochem Health 14:63-68 (1992).
68. Science Advisory Board. Letter Report to the Administrator. EPA-SAB-89-038. Washington, DC:U.S. Environmental Protection Agency, 1989.
69. Science Advisory Board. Review of Arsenic Research Recommendations. EPA-SAB-DWC-92-018. Washington, DC:U.S. Environmental Protection Agency, 1992.
70. Arsenic in Drinking Water Research Needs Report. Report from the international expert workshop sponsored by the American Water Works Research Foundation, 31 May-2 June 1995, Ellicott City, MD. Denver, CO:American Water Works Research Foundation, 1995.
71. Moore MM, Harrington-Brock K, Cabrera M. Biological effects of arsenic exposure: integration of in vitro genotoxicity data with human biomarker data. In: Arsenic Exposure and Health Effects (Abernathy CO, Calderon RL, Chappell WR, eds). New York:Chapman & Hall, 1997;330-337.
72. Klimecki WT, Borchers AH, Egbort RA, Carter DE, Nagle RB, Bowden GT. Effects of acute and chronic exposure of human-derived keratinocytes on an in vitro human skin equivalent system, a novel model of human arsenicism. Toxicol In Vitro 11:89-98 (1997).
73. McKinney JD. Metabolism and disposition of inorganic arsenic in laboratory animals and humans. Environ Geochem Health 14:43-48 (1992).
74. Menzel DB, Ross M, Oddo SV, Bergstrom P, Greene H, Roth RN. A physiologically based pharmacokinetic model for ingested arsenic. In: Arsenic Exposure and Health. Special Issue of Environmental Geochemistry and Health. Science and Technology Letters, Vol 16 (Chappell WR, Abernathy CO, Cothern CR, eds). Middlesex, England:Northwood, 1994;209-218.
75. Mann S, Droz PO, Vahter M. A physiologically based pharmacokinetic model for the four arsenic species in mammals. In: Arsenic Exposure and Health. Special Issue of Environmental Geochemistry and Health. Science and Technology Letters, Vol 16 (Chappell WR, Abernathy CO, Cothern CR, eds). Middlesex, England:Northwood, 1994;219-232.
76. Hsu KH, Froines J, Chen CJ. Studies of arsenic ingestion from drinking water in Northwestern Taiwan: Chemical speciation and urinary metabolites. In: Arsenic Exposure and Health Effects (Abernathy CO, Calderon RL, Chappell WR, eds). New York:Chapman & Hall, 1997;190-209.
77. Smith AH, Hopenhayn-Rich C, Biggs ML, Moore L, Dale J, Warner M, Bates M, Engel R. Epidemiological study designs co address potential high bladder cancer risks from arsenic in drinking water. In: Arsenic Exposure and Health. Special Issue of Environmental Geochemistry and Health. Science and Technology Letters, Vol 16 (Chappell WR, Abernathy CO, Cothern CR, eds). Middlesex, England:Northwood, 1994;109-118.
78. Vahter M, Marafante E. Effects of low dietary intake of methionine, choline, or proteins on the biotransformation of arsenite in the rabbit. Toxicol Lett 37:41-46 (1987).
79. Brown KG, Guo HR, Kuo TL, Greene HL. Skin cancer and inorganic arsenic: uncertainty-status of risk. Risk Anal 17:37-42 (1997).
80. Brown KG, Guo HR, Greene HL. Uncertainty in cancer risk at low doses of inorganic arsenic. Hum Ecol Risk Assess 3:351-362 (1997).
81. Gueschonig H, Irgolic KJ. The mercuric-bromide-stain method and the Natelson method for the determination of arsenic: implications for assessment of risks from exposure to arsenic in Taiwan. In: Arsenic Exposure and Health Effects (Abernathy CO, Calderon RL, Chappell WR, eds). New York:Chapman & Hall, 1997;17-32.
82. Warner ML, Moore LE, Smith MT. Increased micronuclei in exfoliated bladder cells of persons who chronically ingest arsenic-contaminated water in Nevada. Cancer Epidemiol Biomarkers Prev 3:583-590 (1994).
83. Mass MJ, Wang L. Alterations of methylation of the tumor suppressor gene P53: insights into potential mechanisms of arsenic carcinogenesis. In: Arsenic Exposure and Health Effects (Abernathy CO, Calderon RL, Chappell WR, eds). New York:Chapman & Hall, 1997;338-348.
84. Connor JJ, Shacklette HT. Background geochemistry of some rocks, soils, plants, and vegetables in the conterminous United States. USGS Professional Paper 574-F. Washington, DC:U.S. Government Printing Office, 1975.
85. Life Systems, Inc. Toxicological Profile for Arsenic (ATSDR). PB93-182376. Washington, DC:U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry, 1993.
86. Sussman RM, Goldman LR. Memorandum to EPA Administrator. US Environmental Protection Agency, May 31, 1994. Washington, DC:U.S. EPA Science Policy Council, 1994.
87. U.S. Environmental Protection Agency. Proposed Guidelines for Carcinogen Risk Assessment. Fed Reg 61:17959-18011 (1996).
88. SRA Technologies. An epidemiology research strategy for arsenic in drinking water (Draft), 9 August 1994, Research Triangle Park, NC:U.S. EPA Health Effects Research Laboratory.